DEVICE · Unmapped registry intervention
t:slim X2 insulin pump with Control-IQ technology 1.5
Find medicine records ·
Find other trials using this name
Clinical trial
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
NCT05403502
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Tandem Diabetes Care, Inc.lead sponsor
Eli Lilly and Companycollaborator
Jaeb Center for Health Researchcollaborator
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1San AntonioTexas, United States1TampaFlorida, United States1IndianapolisIndiana, United States1AuroraColorado, United States1Kansas CityMissouri, United States1GainesvilleFlorida, United States1OrangeCalifornia, United States1CharlottesvilleVirginia, United States1Palo AltoCalifornia, United States1EvanstonIllinois, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05403502 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.